MS
RVMD icon

Maven Securities’s Revolution Medicines RVMD Stock Holding History

Maven Securities’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,000
Closed -$2.84M – 961
2024
Q4 		$2.84M Buy
+65,000
New +$3.28M 0.07% 224
2023
Q3 		– Sell
-100,000
Closed -$2.67M – 1217
2023
Q2 		$2.67M Buy
100,000
+46,430
+87% +$1.14M 0.04% 225
2023
Q1 		$1.16M Buy
+53,570
New +$1.32M 0.02% 419
2021
Q2 		– Sell
-34,012
Closed -$1.51M – 1293
2021
Q1 		$1.51M Buy
+34,012
New +$1.53M 0.07% 276

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maven Securities's RVMD Position: Q1 2025 in Review

Maven Securities sold out of Revolution Medicines (RVMD) in Q1 2025, closing a stake of 65,000 shares — an estimated $2.84M sold.

Maven Securities first reported a position in RVMD in Q1 2021 and held it in 4 quarters. The position peaked at $2.84M in Q4 2024. 284 funds tracked by Wall St. Rank hold RVMD as of Q1 2025.

  • Maven Securities reported no remaining Revolution Medicines position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 65,000 Revolution Medicines shares in Q1 2025, an estimated $2.84M.
  • Maven Securities first reported a position in Revolution Medicines in Q1 2021 and held it in 4 quarters.
  • Maven Securities's Revolution Medicines position peaked at $2.84M in Q4 2024.
  • 284 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.